Why the study?
Is the Russian version of the MacNew Heart Disease Health-related Quality of Life Scale a reliable and valid tool for assessing quality of life in patients undergoing CABG surgery?
Is the Russian version of the MacNew Heart Disease Health-related Quality of Life Scale a reliable and valid tool for assessing quality of life in patients undergoing CABG surgery?
The Russian version of the MacNew questionnaire is a reliable, valid, and responsive tool for assessing health-related quality of life in patients undergoing CABG surgery.
Answers are grounded in this paper and cite their sources.
Supports Russian MacNew for CABG QoL assessment; extends validation but leaves open broader adoption.
Rationale and aims: The MacNew questionnaire is a disease-specific health-related quality of life (HRQL) measure designed for patients with heart disease. We aimed to assess the psychometric properties of the Russian MacNew heart-disease health-related quality of life (HRQL) scale in patients undergoing coronary artery bypass grafting (CABG) surgery.Methods: The sample comprised of 226 Russian-speaking CABG patients. Patients were assessed before CABG surgery and 12 months thereafter. They completed the MacNew, the Short Form-36 Health Survey (SF-36), the Hospital Anxiety and Depression Scale and a questionnaire on demographic and lifestyle habits.Results: Of the 226 patients who completed the questionnaires at study entry, 188 (83%) also provided data after 12 months. The internal consistency of the MacNew scales was high (alpha coefficients: 0.88-0.93). There were moderate to high correlations between similar sub-scales of the MacNew and the SF-36 domains (0.69-0.80). The MacNew scales discriminated between patients varying on four variables: gender, depression, anxiety and congestive heart failure. The original 3-factor structure was generally supported. Patients’ scores on the MacNew scale improved over 12 months suggesting it was responsive to change.Conclusions: The Russian version of MacNew was found to be a reliable and valid HRQL tool which is sensitive to change. This instrument offers clinicians and researchers a useful tool for understanding patient’s perspective of the impact of heart disease and its treatment.
No takes yet. Share an insight, caveat, or question.
Geulayov et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: